Placeholder Banner

2016 BIO International Convention Adds More Events to Already Robust Program

June 1, 2016

Washington, D.C. (June 1, 2016) – The Biotechnology Innovation Organization (BIO) today announced that two additional Fireside Chats will be added to the 2016 BIO International Convention program. Also announced, were the winners of its “Future Makers in Biotech” contest in which individuals were nominated by their peers for vision, innovation, and advancements in biotechnology.

Now included in the four-day Convention are:

A One-on-one with Mark Alles, Chief Executive Officer, Celgene - BIO’s President and CEO, Jim Greenwood, will chat with Dr. Mark Alles, Chief Executive Officer (CEO) of Celgene Corporation.  Celgene is a global integrated biopharmaceutical company primarily engaged in the discovery, development, and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. The event will be from 3:30 - 4:30 PM on June 7, Room West 3011; and

A Panel Discussion on the International Space Station: How Microgravity Impacts Life Sciences Both on the Road to Mars and Here on Earth - CNN Correspondent Rachel Crane will moderate a panel discussion on how the International Space Station and its microgravity environment is providing insight into better understanding of the human condition. As NASA embarks on its “Journey to Mars,” panelists will explore how the orbiting laboratory is enabling the BioPharma community access and opportunity to attack disease in a manner never before possible. Astronaut Michael Barratt will join the discussion along with NASA leadership on the physical strains of microgravity. Crane will also speak with BioPharma industry leaders about microgravity and medical research. The session will run from 2:00 – 3:00 PM on June 8, Room West 3011.

Previously announced Fireside Chats with Dr. Robert Califf, US Food and Drug Administration Commissioner and Janet Napolitano, University of California President will be held on June 7 at 11:00 AM and 2:00 PM respectively.

Also announced today were the Future Makers in Biotech winners. Selected through online voting, the winners will be recognized during the Convention in the Imagination Incubator – an interactive demo area located in the first floor lobby of Moscone West. Each will give a 15-20 minute talk relaying his/her inspiring personal story and vision for the future. The informal presentations will be made during a “Think and Drink” session from 3:00 – 4:30 PM on Wednesday, June 8. The winners include:

Howard Jacob, PhD - The first person in history to use genome sequencing to diagnose, treat and cure a patient, Jacob launched the world's first genomic medicine program: HudsonAlpha, a nonprofit research institute.

Charles A. Mohan, Jr. – Charles started the United Mitochondrial Disease Foundation (UMDF) in the basement of his Monroeville, PA home in 1996.  UMDF is now internationally recognized as the leading patient advocacy group for mitochondrial disease.

Alison Van Eenennaam, PhD -An Animal Genomics and Biotechnology Cooperative Extension Specialist in the Department of Animal Science at the University of California, Davis, Dr. Van Eenennaam focuses on the use of animal genomics and biotechnology in livestock production systems.

“From biomedical research conducted in outer space to breakthroughs in genome sequencing that are allowing us to cure previously incurable diseases, BIO’s featured speakers will showcase a transformative new era of medicine pulled straight from the pages of science fiction,” said BIO President and CEO, Jim Greenwood. “Our fireside chats will explore how the study of microgravity environments can lead to new treatments down on planet Earth and how Celgene’s dynamic new CEO plans to steer his company in pursuit of novel cancer therapies. We will discover how three BIO Future Makers are incubating new ideas to reshape genomics and improve lives. The future of biotechnology has arrived.”

Advance media registration for the 2016 BIO International Convention is now available for qualified reporters working full time for print, broadcast and web publications with valid press credentials. To register, please visit here.


About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.


Upcoming BIO Events 

BIO International Convention
June 6-9, 2016
San Francisco, CA

BIO Animal Biotech Summit
September 21-23, 2016
Bethesda, MD

BIO Investor Forum
October 18-19, 2016
San Francisco, CA

BIO Latin America Conference
October 26-28, 2016
Grand Hyatt São Paulo, Brazil

Discover More
Washington, DC (December 2, 2020) - Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement regarding Nasdaq's filing with the Securities and Exchange Commission…
Washington, DC (November 20, 2020) – Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the Trump administration moved forward with its threat to impose…
"What a historic election for our country! For the first time in 120 years, American voter participation shattered many turnout records.    "At BIO we undertook an effort to mobilize and activate voters in our industry with Biotech Votes…